Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophrenia

J.H. Schoemaker*, A.J.J.M. Vingerhoets, Robin Emsley

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

1 Citation (Scopus)

Abstract

Introduction Despite consistently high discontinuation rates due to withdrawal of consent (WOC) and insufficient therapeutic effect (ITE) in schizophrenia trials, insight into the underlying factors contributing to poor satisfaction with treatment and dropout is limited. A better understanding of these factors could help to improve trial design and completion rates. Methods Using data from 1,136 trial participants with schizophrenia or schizoaffective disorder, we explored associations between predictor variables with (1) dropout due to WOC and ITE and (2) satisfaction with treatment among patients and investigators by means of hierarchic multiple regression analyses. Results ITE was associated with poor clinical improvement, poor investigator satisfaction with treatment, and poor patient insight into their own disease, whereas WOC only showed a meaningful association with poor patient satisfaction with treatment. Investigator satisfaction with treatment appeared most strongly associated with Positive and Negative Syndrome Scale (PANSS) positive factor endpoint scores, whereas patient satisfaction with treatment was best predicted by the endpoint score on the PANSS emotional distress factor. The occurrence of severe side effects showed no meaningful association to satisfaction with treatment among investigators and patients, and neither did a patient's experienced psychopathology, nor their self-rating of functional impairment. Conclusions Whereas trial discontinuation due to ITE is associated with poor treatment effectiveness, a patient's decision to withdraw from an antipsychotic trial remains unpredictable and may occur even when the investigator observes a global clinical improvement and is satisfied with the treatment.

Original languageEnglish
Pages (from-to)380-389
JournalCNS Spectrums
Volume24
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • ADHERENCE
  • ANTIPSYCHOTIC MEDICATIONS
  • DETERMINANTS
  • DOUBLE-BLIND
  • FUNCTIONAL OUTCOMES
  • ILLNESS SEVERITY
  • MEDICATION NONADHERENCE
  • QUALITY-OF-LIFE
  • SUBJECTIVE EXPERIENCES
  • SYNDROME SCALE PANSS
  • Schizophrenia
  • dropout
  • predictors
  • randomized controlled trial
  • satisfaction with treatment

Fingerprint Dive into the research topics of 'Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophrenia'. Together they form a unique fingerprint.

  • Cite this